Skip to main content
Log in

Effect of Antiorthostatic Hypokinesia on the Pharmacokinetics and Bioavailability of Propranolol

  • MOLECULAR-BIOLOGICAL PROBLEMS OF DRUG DESIGN AND MECHANISM OF DRUG ACTION
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

The pharmacokinetics of propranolol were studied in healthy volunteers after a single peroral administration at a dose of 80 mg under normal conditions, on the second day of antiorthostatic hypokinesia, and on the first day after termination of the hypokinesia. The maximum propranolol concentration (–6 ∆%), area under the pharmacokinetic curve (–13 ∆%), elimination half-life (–15 ∆%), mean residence time in the body (–17 ∆%), and distribution volume (–8 ∆%) tended to decrease with antiorthostatic hypokinesia whereas the total clearance (+13 ∆%), ratio of maximum concentrations (125 ± 23%), and relative absorption rate of the drug (158 ± 48%) increased.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  1. A. I. Grigoriev and A. D. Egorov, in: Advances in Space Biology and Medicine, S. L. Bonting (ed.), Vol. 2, Elsevier, London (1992), pp. 1 – 42.

    Chapter  Google Scholar 

  2. L. Putcha, N. M. Cintron, and J. M. Vanderploeg, in: Annual Scientific Meeting of the Aerospace Medical Association, Washington (1989).

  3. I. V. Kovachevich, S. N. Kondratenko, A. K. Starodubtsev, and L. G. Repenkova, Khim.-farm. Zh., 43(3), 8 – 11 (2009); Pharm. Chem. J., 43(3), 130 – 133 (2009).

  4. N. M. Cintron, H. W. Lane, and C. S. Leach, Physiologist, 33(1), 16 – 19 (1990).

    Google Scholar 

  5. T. V. Saprygina, Yu. R. Petrosyan, A. B. Kazaryan, and V. G. Kukes, Khim.-farm. Zh., 23(9), 1143 – 1146 (1989).

    CAS  Google Scholar 

  6. A. A. Agafonov and V. K. Piotrovskii, Khim.-farm. Zh., 25(10), 16 – 19 (1991).

    CAS  Google Scholar 

  7. I. B. Bondareva, S. V. Budanov, N. D. Bunyatyan, et al., Assessment of Drug Bioequivalence, Methodical Instructions [in Russian], Moscow (2008), p. 19.

  8. L. E. Kholodov and V. P. Yakovlev, Clinical Pharmacokinetics [in Russian], Moscow (1985).

  9. T. Walle, T. C. Tagan, K. Walle, et al., Clin. Pharmacol. Ther., 30(6), 790 – 795 (1981).

    Article  CAS  PubMed  Google Scholar 

  10. I. B. Goncharov, I. V. Kovachevich, L. G. Repenkova, et al., Khim.-farm. Zh., 43(5), 3 – 6 (2009); Pharm. Chem. J., 43(5), 235 – 238 (2009).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. N. Kondratenko.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 52, No. 6, pp. 3 – 6, June, 2018.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kondratenko, S.N., Kovachevich, I.V. & Repenkova, L.G. Effect of Antiorthostatic Hypokinesia on the Pharmacokinetics and Bioavailability of Propranolol. Pharm Chem J 52, 491–494 (2018). https://doi.org/10.1007/s11094-018-1845-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-018-1845-y

Keywords

Navigation